Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 88

1.

Aggravation of fatigue by steroid therapy in terminally ill patients with cancer.

Matsuo N, Yomiya K.

Am J Hosp Palliat Care. 2014 May;31(3):341-4. doi: 10.1177/1049909113485280. Epub 2013 Apr 15.

PMID:
23588576
2.

Can "steroid switching" improve steroid-induced psychosis in a patient with advanced cancer?

Okishiro N, Tanimukai H, Tsuneto S, Ito N.

J Palliat Med. 2009 May;12(5):487-90. doi: 10.1089/jpm.2009.9628.

PMID:
19416050
3.

Can "steroid switching" improve steroid-induced musical hallucinations in a patient with terminal cancer?

Kanemura S, Tanimukai H, Tsuneto S.

J Palliat Med. 2010 Dec;13(12):1495-8. doi: 10.1089/jpm.2010.9751.

PMID:
21155649
4.

Acute myopathy following intra-muscular injection of compound betamethasone: A case report.

Sun LY, Chu XL.

Medicine (Baltimore). 2017 Aug;96(34):e7474. doi: 10.1097/MD.0000000000007474.

5.

[Effect of betamethasone in blood glucose levels in pregnant diabetic women at risk of preterm birth].

Ramírez-Torres MA, Pérez-Monter SE, Espino y Sosa S, Ibargüengoitia-Ochoa F.

Ginecol Obstet Mex. 2011 Sep;79(9):565-71. Spanish.

PMID:
21966858
6.

The effects of epidural betamethasone on blood glucose in patients with diabetes mellitus.

Gonzalez P, Laker SR, Sullivan W, Harwood JE, Akuthota V.

PM R. 2009 Apr;1(4):340-5. doi: 10.1016/j.pmrj.2008.12.007.

PMID:
19627917
7.

[Steroid-induced myopathy. Clinical and muscle pathologic aspects with a case report].

Mellgren SI, Johnsen HJ.

Tidsskr Nor Laegeforen. 1979 Feb 28;99(3):163-4. Norwegian. No abstract available.

PMID:
419494
9.

Predictors of the Usefulness of Corticosteroids for Cancer-Related Fatigue in End-of-Life Patients.

Kanbayashi Y, Hosokawa T.

Clin Drug Investig. 2017 Apr;37(4):387-392. doi: 10.1007/s40261-017-0493-4.

PMID:
28101697
10.

[Severe steroid-induced myopathy].

Araszkiewicz Z, Polubiec-Kownacka M.

Pneumonol Pol. 1989 Jul-Sep;57(7-9):426-8. Polish.

PMID:
2636374
11.

[Case of steroid myopathy].

Morita H, Hosokawa Z.

Naika. 1968 Apr;21(4):775-80. Japanese. No abstract available.

PMID:
5248013
12.

The role of physical and psychological symptoms in desire for death: a study of terminally ill cancer patients.

Mystakidou K, Parpa E, Katsouda E, Galanos A, Vlahos L.

Psychooncology. 2006 Apr;15(4):355-60.

PMID:
16184617
13.

Topical ocular drug delivery to inner ear disease and sinusitis.

Mimura T, Funatsu H, Usui T, Yamagami S, Noma H, Amano S.

South Med J. 2006 Nov;99(11):1287-9.

PMID:
17195427
14.

Preliminary report: vitamin D deficiency in advanced cancer patients with symptoms of fatigue or anorexia.

Dev R, Del Fabbro E, Schwartz GG, Hui D, Palla SL, Gutierrez N, Bruera E.

Oncologist. 2011;16(11):1637-41. doi: 10.1634/theoncologist.2011-0151. Epub 2011 Sep 30.

15.

Dose-sensitive steroid-induced hyperglycaemia.

Gannon C, Dando N.

Palliat Med. 2010 Oct;24(7):737-9. doi: 10.1177/0269216310377816. Epub 2010 Aug 4.

PMID:
20685772
16.

Plasma interleukin-6 and fatigue in terminally ill cancer patients.

Inagaki M, Isono M, Okuyama T, Sugawara Y, Akechi T, Akizuki N, Fujimori M, Mizuno M, Shima Y, Kinoshita H, Uchitomi Y.

J Pain Symptom Manage. 2008 Feb;35(2):153-61. Epub 2007 Dec 21.

PMID:
18082358
17.

Psoriatic arthritis and myopathy.

Thomson GT, Johnston JL, Baragar FD, Toole JW.

J Rheumatol. 1990 Mar;17(3):395-8.

PMID:
2110253
18.

Steroid myopathy in cancer patients.

Batchelor TT, Taylor LP, Thaler HT, Posner JB, DeAngelis LM.

Neurology. 1997 May;48(5):1234-8.

PMID:
9153449
19.

Evidence-based recommendations for cancer fatigue, anorexia, depression, and dyspnea.

Dy SM, Lorenz KA, Naeim A, Sanati H, Walling A, Asch SM.

J Clin Oncol. 2008 Aug 10;26(23):3886-95. doi: 10.1200/JCO.2007.15.9525. Review.

PMID:
18688057
20.

Review of clinical trials of pharmacologic interventions for cancer-related fatigue: focus on psychostimulants and steroids.

Yennurajalingam S, Bruera E.

Cancer J. 2014 Sep-Oct;20(5):319-24. doi: 10.1097/PPO.0000000000000069. Review.

PMID:
25299141

Supplemental Content

Support Center